Filters
Other countries
Results: 1 to 18 of 18
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
NGS Panel for Congenital and Acquired Sideroblastic Anemia BloodGenetics Spain | 18 | 17 |
|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
LARS2 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Invitae Leukodystrophy and Genetic Leukoencephalopathy Panel Invitae United States | 971 | 680 |
|
Invitae Inborn Errors of Immunity and Cytopenias Panel Invitae United States | 755 | 562 |
|
Invitae Nuclear Mitochondrial Disorders Panel Invitae United States | 394 | 319 |
|
Invitae Iron Related Disorders Panel Invitae United States | 39 | 27 |
|
Invitae Comprehensive Deafness Panel Invitae United States | 405 | 219 |
|
Mitochondrial Disorders Panel (Nuclear Genes Only) PreventionGenetics United States | 292 | 253 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Hereditary Hearing Loss and Deafness Panel PreventionGenetics United States | 356 | 211 |
|
Hereditary ataxias. NGS panel of 139 genes. Genologica Medica Spain | 220 | 139 |
|
Ataxia panel. NGS panel of 157 genes. Genologica Medica Spain | 247 | 156 |
|
Mitochondrial genome sequencing Molecular Vision Laboratory United States | 526 | 339 |
|
Mitochondrial Panel, Nuclear genes CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 145 | 134 |
|
Hearing Loss, Comprehensive Panel CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 142 | 84 |
|
Mitochondrial Diseases (mtDNA and 217 nuclear genes) Asper Biogene Asper Biogene LLC Estonia | 89 | 210 |
|
Results: 1 to 18 of 18
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.